TWO SIGMA INVESTMENTS, LP - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 40 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$398,590
-31.5%
273,007
+7.4%
0.00%0.0%
Q2 2023$582,242
+213.6%
254,254
+24.6%
0.00%0.0%
Q1 2023$185,683
-22.3%
204,047
-27.4%
0.00%0.0%
Q4 2022$239,009
-32.1%
281,187
-34.6%
0.00%0.0%
Q3 2022$352,000
-1.4%
429,708
+19.0%
0.00%0.0%
Q2 2022$357,000
-56.8%
361,034
-28.4%
0.00%
-50.0%
Q1 2022$827,000
-63.1%
504,155
-45.8%
0.00%
-60.0%
Q4 2021$2,242,000
+229.7%
930,447
+562.5%
0.01%
+150.0%
Q3 2021$680,000
-17.8%
140,455
-54.6%
0.00%0.0%
Q2 2021$827,000
-23.0%
309,653
-11.2%
0.00%
-33.3%
Q1 2021$1,074,000
+678.3%
348,756
+586.9%
0.00%
+200.0%
Q2 2020$138,000
-34.0%
50,776
-48.8%
0.00%
-50.0%
Q1 2020$209,000
-64.6%
99,258
-8.6%
0.00%0.0%
Q4 2019$591,000
+206.2%
108,599
+69.6%
0.00%
+100.0%
Q3 2019$193,000
+10.3%
64,048
+36.6%
0.00%0.0%
Q2 2019$175,000
-31.9%
46,904
-26.6%
0.00%0.0%
Q1 2019$257,000
+2.0%
63,861
-7.0%
0.00%0.0%
Q4 2018$252,00068,7000.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 3,101,709$7,475,0001.50%
ADAMS STREET PARTNERS LLC 3,275,616$7,894,0001.20%
Telemetry Investments, L.L.C. 192,909$465,0000.60%
CHI Advisors LLC 400,000$964,0000.32%
Orbimed Advisors 6,943,654$16,734,0000.22%
Ikarian Capital, LLC 482,610$1,163,0000.17%
Anson Funds Management LP 528,358$1,273,0000.12%
BVF INC/IL 1,370,947$3,304,0000.12%
VR Adviser, LLC 250,000$603,0000.08%
PURA VIDA INVESTMENTS, LLC 492,384$1,187,0000.04%
View complete list of CORVUS PHARMACEUTICALS INC shareholders